Molecular Methods Comprehensive Study by Type (Polymerase Chain Reaction (PCR), Immunoassay, Biosensors, Microarray, Others), Application (Instrument, Reagents & Consumables, Services) Players and Region - Global Market Outlook to 2030

Molecular Methods Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 6.9%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Molecular Methods
The improvement in food safety regulations, rapid advancement in automation of food testing protocols, increasing occurrence of food-borne illness, growing demand of the packaged and organic food products will accelerate the growth of the molecular methods market.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR6.9%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Molecular Methods market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

QIAGEN (Germany), 3M (United States), Veredus Laboratories (Singapore), Neogen Corporation (United States), Thermo Fisher Scientific (United States), Bio-Rad Laboratories (United States), bioMérieux SA (France), ArcherDX (United States) and HiMedia Laboratories (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Eurofins Scientific (Luxembourg) and SGS (Switzerland).

Segmentation Overview
AMA Research has segmented the market of Global Molecular Methods market by Type (Polymerase Chain Reaction (PCR), Immunoassay, Biosensors, Microarray and Others), Application (Instrument, Reagents & Consumables and Services) and Region.



On the basis of geography, the market of Molecular Methods has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Growth Drivers:
Improvement in food safety regulations, Introduction of automation in food testing protocols and Growing burden of foodborne illness

Challenges:
Budget and resources constraints

Restraints:
High cost of advanced molecular testing equipment and Lack of food safety awareness in developing economies

Opportunities:
Growth opportunities in emerging countries and Rising focus on R&D and funding in molecular Methods

Market Leaders and their expansionary development strategies
In January 2024, hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, and Orano Med, a pioneer in targeted alpha therapy, have announced a collaboration to develop novel Radio-DARPin therapeutics (RDTs) that use Orano Med’s 212Pb radioisotope as a payload to selectively kill cancer cells. Both companies will leverage their unique capabilities to enable rapid clinical development and agree to share costs for preclinical and clinical development for multiple oncology targets, the first of which is DLL3.



Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Molecular Methods Provider, Venture Capitalists and Private Equity Firms and End-Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Polymerase Chain Reaction (PCR)
  • Immunoassay
  • Biosensors
  • Microarray
  • Others
By Application
  • Instrument
  • Reagents & Consumables
  • Services
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Improvement in food safety regulations
      • 3.2.2. Introduction of automation in food testing protocols
      • 3.2.3. Growing burden of foodborne illness
    • 3.3. Market Challenges
      • 3.3.1. Budget and resources constraints
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Molecular Methods, by Type, Application and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Molecular Methods (Value)
      • 5.2.1. Global Molecular Methods by: Type (Value)
        • 5.2.1.1. Polymerase Chain Reaction (PCR)
        • 5.2.1.2. Immunoassay
        • 5.2.1.3. Biosensors
        • 5.2.1.4. Microarray
        • 5.2.1.5. Others
      • 5.2.2. Global Molecular Methods by: Application (Value)
        • 5.2.2.1. Instrument
        • 5.2.2.2. Reagents & Consumables
        • 5.2.2.3. Services
      • 5.2.3. Global Molecular Methods Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Molecular Methods: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. QIAGEN (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. 3M (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Veredus Laboratories (Singapore)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Neogen Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Thermo Fisher Scientific (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bio-Rad Laboratories (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BioMérieux SA (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ArcherDX (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. HiMedia Laboratories (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Molecular Methods Sale, by Type, Application and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Molecular Methods (Value)
      • 7.2.1. Global Molecular Methods by: Type (Value)
        • 7.2.1.1. Polymerase Chain Reaction (PCR)
        • 7.2.1.2. Immunoassay
        • 7.2.1.3. Biosensors
        • 7.2.1.4. Microarray
        • 7.2.1.5. Others
      • 7.2.2. Global Molecular Methods by: Application (Value)
        • 7.2.2.1. Instrument
        • 7.2.2.2. Reagents & Consumables
        • 7.2.2.3. Services
      • 7.2.3. Global Molecular Methods Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Molecular Methods: by Type(USD Million)
  • Table 2. Molecular Methods Polymerase Chain Reaction (PCR) , by Region USD Million (2018-2023)
  • Table 3. Molecular Methods Immunoassay , by Region USD Million (2018-2023)
  • Table 4. Molecular Methods Biosensors , by Region USD Million (2018-2023)
  • Table 5. Molecular Methods Microarray , by Region USD Million (2018-2023)
  • Table 6. Molecular Methods Others , by Region USD Million (2018-2023)
  • Table 7. Molecular Methods: by Application(USD Million)
  • Table 8. Molecular Methods Instrument , by Region USD Million (2018-2023)
  • Table 9. Molecular Methods Reagents & Consumables , by Region USD Million (2018-2023)
  • Table 10. Molecular Methods Services , by Region USD Million (2018-2023)
  • Table 11. South America Molecular Methods, by Country USD Million (2018-2023)
  • Table 12. South America Molecular Methods, by Type USD Million (2018-2023)
  • Table 13. South America Molecular Methods, by Application USD Million (2018-2023)
  • Table 14. Brazil Molecular Methods, by Type USD Million (2018-2023)
  • Table 15. Brazil Molecular Methods, by Application USD Million (2018-2023)
  • Table 16. Argentina Molecular Methods, by Type USD Million (2018-2023)
  • Table 17. Argentina Molecular Methods, by Application USD Million (2018-2023)
  • Table 18. Rest of South America Molecular Methods, by Type USD Million (2018-2023)
  • Table 19. Rest of South America Molecular Methods, by Application USD Million (2018-2023)
  • Table 20. Asia Pacific Molecular Methods, by Country USD Million (2018-2023)
  • Table 21. Asia Pacific Molecular Methods, by Type USD Million (2018-2023)
  • Table 22. Asia Pacific Molecular Methods, by Application USD Million (2018-2023)
  • Table 23. China Molecular Methods, by Type USD Million (2018-2023)
  • Table 24. China Molecular Methods, by Application USD Million (2018-2023)
  • Table 25. Japan Molecular Methods, by Type USD Million (2018-2023)
  • Table 26. Japan Molecular Methods, by Application USD Million (2018-2023)
  • Table 27. India Molecular Methods, by Type USD Million (2018-2023)
  • Table 28. India Molecular Methods, by Application USD Million (2018-2023)
  • Table 29. South Korea Molecular Methods, by Type USD Million (2018-2023)
  • Table 30. South Korea Molecular Methods, by Application USD Million (2018-2023)
  • Table 31. Taiwan Molecular Methods, by Type USD Million (2018-2023)
  • Table 32. Taiwan Molecular Methods, by Application USD Million (2018-2023)
  • Table 33. Australia Molecular Methods, by Type USD Million (2018-2023)
  • Table 34. Australia Molecular Methods, by Application USD Million (2018-2023)
  • Table 35. Rest of Asia-Pacific Molecular Methods, by Type USD Million (2018-2023)
  • Table 36. Rest of Asia-Pacific Molecular Methods, by Application USD Million (2018-2023)
  • Table 37. Europe Molecular Methods, by Country USD Million (2018-2023)
  • Table 38. Europe Molecular Methods, by Type USD Million (2018-2023)
  • Table 39. Europe Molecular Methods, by Application USD Million (2018-2023)
  • Table 40. Germany Molecular Methods, by Type USD Million (2018-2023)
  • Table 41. Germany Molecular Methods, by Application USD Million (2018-2023)
  • Table 42. France Molecular Methods, by Type USD Million (2018-2023)
  • Table 43. France Molecular Methods, by Application USD Million (2018-2023)
  • Table 44. Italy Molecular Methods, by Type USD Million (2018-2023)
  • Table 45. Italy Molecular Methods, by Application USD Million (2018-2023)
  • Table 46. United Kingdom Molecular Methods, by Type USD Million (2018-2023)
  • Table 47. United Kingdom Molecular Methods, by Application USD Million (2018-2023)
  • Table 48. Netherlands Molecular Methods, by Type USD Million (2018-2023)
  • Table 49. Netherlands Molecular Methods, by Application USD Million (2018-2023)
  • Table 50. Rest of Europe Molecular Methods, by Type USD Million (2018-2023)
  • Table 51. Rest of Europe Molecular Methods, by Application USD Million (2018-2023)
  • Table 52. MEA Molecular Methods, by Country USD Million (2018-2023)
  • Table 53. MEA Molecular Methods, by Type USD Million (2018-2023)
  • Table 54. MEA Molecular Methods, by Application USD Million (2018-2023)
  • Table 55. Middle East Molecular Methods, by Type USD Million (2018-2023)
  • Table 56. Middle East Molecular Methods, by Application USD Million (2018-2023)
  • Table 57. Africa Molecular Methods, by Type USD Million (2018-2023)
  • Table 58. Africa Molecular Methods, by Application USD Million (2018-2023)
  • Table 59. North America Molecular Methods, by Country USD Million (2018-2023)
  • Table 60. North America Molecular Methods, by Type USD Million (2018-2023)
  • Table 61. North America Molecular Methods, by Application USD Million (2018-2023)
  • Table 62. United States Molecular Methods, by Type USD Million (2018-2023)
  • Table 63. United States Molecular Methods, by Application USD Million (2018-2023)
  • Table 64. Canada Molecular Methods, by Type USD Million (2018-2023)
  • Table 65. Canada Molecular Methods, by Application USD Million (2018-2023)
  • Table 66. Mexico Molecular Methods, by Type USD Million (2018-2023)
  • Table 67. Mexico Molecular Methods, by Application USD Million (2018-2023)
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Molecular Methods: by Type(USD Million)
  • Table 78. Molecular Methods Polymerase Chain Reaction (PCR) , by Region USD Million (2025-2030)
  • Table 79. Molecular Methods Immunoassay , by Region USD Million (2025-2030)
  • Table 80. Molecular Methods Biosensors , by Region USD Million (2025-2030)
  • Table 81. Molecular Methods Microarray , by Region USD Million (2025-2030)
  • Table 82. Molecular Methods Others , by Region USD Million (2025-2030)
  • Table 83. Molecular Methods: by Application(USD Million)
  • Table 84. Molecular Methods Instrument , by Region USD Million (2025-2030)
  • Table 85. Molecular Methods Reagents & Consumables , by Region USD Million (2025-2030)
  • Table 86. Molecular Methods Services , by Region USD Million (2025-2030)
  • Table 87. South America Molecular Methods, by Country USD Million (2025-2030)
  • Table 88. South America Molecular Methods, by Type USD Million (2025-2030)
  • Table 89. South America Molecular Methods, by Application USD Million (2025-2030)
  • Table 90. Brazil Molecular Methods, by Type USD Million (2025-2030)
  • Table 91. Brazil Molecular Methods, by Application USD Million (2025-2030)
  • Table 92. Argentina Molecular Methods, by Type USD Million (2025-2030)
  • Table 93. Argentina Molecular Methods, by Application USD Million (2025-2030)
  • Table 94. Rest of South America Molecular Methods, by Type USD Million (2025-2030)
  • Table 95. Rest of South America Molecular Methods, by Application USD Million (2025-2030)
  • Table 96. Asia Pacific Molecular Methods, by Country USD Million (2025-2030)
  • Table 97. Asia Pacific Molecular Methods, by Type USD Million (2025-2030)
  • Table 98. Asia Pacific Molecular Methods, by Application USD Million (2025-2030)
  • Table 99. China Molecular Methods, by Type USD Million (2025-2030)
  • Table 100. China Molecular Methods, by Application USD Million (2025-2030)
  • Table 101. Japan Molecular Methods, by Type USD Million (2025-2030)
  • Table 102. Japan Molecular Methods, by Application USD Million (2025-2030)
  • Table 103. India Molecular Methods, by Type USD Million (2025-2030)
  • Table 104. India Molecular Methods, by Application USD Million (2025-2030)
  • Table 105. South Korea Molecular Methods, by Type USD Million (2025-2030)
  • Table 106. South Korea Molecular Methods, by Application USD Million (2025-2030)
  • Table 107. Taiwan Molecular Methods, by Type USD Million (2025-2030)
  • Table 108. Taiwan Molecular Methods, by Application USD Million (2025-2030)
  • Table 109. Australia Molecular Methods, by Type USD Million (2025-2030)
  • Table 110. Australia Molecular Methods, by Application USD Million (2025-2030)
  • Table 111. Rest of Asia-Pacific Molecular Methods, by Type USD Million (2025-2030)
  • Table 112. Rest of Asia-Pacific Molecular Methods, by Application USD Million (2025-2030)
  • Table 113. Europe Molecular Methods, by Country USD Million (2025-2030)
  • Table 114. Europe Molecular Methods, by Type USD Million (2025-2030)
  • Table 115. Europe Molecular Methods, by Application USD Million (2025-2030)
  • Table 116. Germany Molecular Methods, by Type USD Million (2025-2030)
  • Table 117. Germany Molecular Methods, by Application USD Million (2025-2030)
  • Table 118. France Molecular Methods, by Type USD Million (2025-2030)
  • Table 119. France Molecular Methods, by Application USD Million (2025-2030)
  • Table 120. Italy Molecular Methods, by Type USD Million (2025-2030)
  • Table 121. Italy Molecular Methods, by Application USD Million (2025-2030)
  • Table 122. United Kingdom Molecular Methods, by Type USD Million (2025-2030)
  • Table 123. United Kingdom Molecular Methods, by Application USD Million (2025-2030)
  • Table 124. Netherlands Molecular Methods, by Type USD Million (2025-2030)
  • Table 125. Netherlands Molecular Methods, by Application USD Million (2025-2030)
  • Table 126. Rest of Europe Molecular Methods, by Type USD Million (2025-2030)
  • Table 127. Rest of Europe Molecular Methods, by Application USD Million (2025-2030)
  • Table 128. MEA Molecular Methods, by Country USD Million (2025-2030)
  • Table 129. MEA Molecular Methods, by Type USD Million (2025-2030)
  • Table 130. MEA Molecular Methods, by Application USD Million (2025-2030)
  • Table 131. Middle East Molecular Methods, by Type USD Million (2025-2030)
  • Table 132. Middle East Molecular Methods, by Application USD Million (2025-2030)
  • Table 133. Africa Molecular Methods, by Type USD Million (2025-2030)
  • Table 134. Africa Molecular Methods, by Application USD Million (2025-2030)
  • Table 135. North America Molecular Methods, by Country USD Million (2025-2030)
  • Table 136. North America Molecular Methods, by Type USD Million (2025-2030)
  • Table 137. North America Molecular Methods, by Application USD Million (2025-2030)
  • Table 138. United States Molecular Methods, by Type USD Million (2025-2030)
  • Table 139. United States Molecular Methods, by Application USD Million (2025-2030)
  • Table 140. Canada Molecular Methods, by Type USD Million (2025-2030)
  • Table 141. Canada Molecular Methods, by Application USD Million (2025-2030)
  • Table 142. Mexico Molecular Methods, by Type USD Million (2025-2030)
  • Table 143. Mexico Molecular Methods, by Application USD Million (2025-2030)
  • Table 144. Research Programs/Design for This Report
  • Table 145. Key Data Information from Secondary Sources
  • Table 146. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Molecular Methods: by Type USD Million (2018-2023)
  • Figure 5. Global Molecular Methods: by Application USD Million (2018-2023)
  • Figure 6. South America Molecular Methods Share (%), by Country
  • Figure 7. Asia Pacific Molecular Methods Share (%), by Country
  • Figure 8. Europe Molecular Methods Share (%), by Country
  • Figure 9. MEA Molecular Methods Share (%), by Country
  • Figure 10. North America Molecular Methods Share (%), by Country
  • Figure 11. Global Molecular Methods share by Players 2023 (%)
  • Figure 12. Global Molecular Methods share by Players (Top 3) 2023(%)
  • Figure 13. Global Molecular Methods share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. QIAGEN (Germany) Revenue, Net Income and Gross profit
  • Figure 16. QIAGEN (Germany) Revenue: by Geography 2023
  • Figure 17. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 18. 3M (United States) Revenue: by Geography 2023
  • Figure 19. Veredus Laboratories (Singapore) Revenue, Net Income and Gross profit
  • Figure 20. Veredus Laboratories (Singapore) Revenue: by Geography 2023
  • Figure 21. Neogen Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Neogen Corporation (United States) Revenue: by Geography 2023
  • Figure 23. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 24. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 25. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 26. Bio-Rad Laboratories (United States) Revenue: by Geography 2023
  • Figure 27. BioMérieux SA (France) Revenue, Net Income and Gross profit
  • Figure 28. BioMérieux SA (France) Revenue: by Geography 2023
  • Figure 29. ArcherDX (United States) Revenue, Net Income and Gross profit
  • Figure 30. ArcherDX (United States) Revenue: by Geography 2023
  • Figure 31. HiMedia Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 32. HiMedia Laboratories (United States) Revenue: by Geography 2023
  • Figure 33. Global Molecular Methods: by Type USD Million (2025-2030)
  • Figure 34. Global Molecular Methods: by Application USD Million (2025-2030)
  • Figure 35. South America Molecular Methods Share (%), by Country
  • Figure 36. Asia Pacific Molecular Methods Share (%), by Country
  • Figure 37. Europe Molecular Methods Share (%), by Country
  • Figure 38. MEA Molecular Methods Share (%), by Country
  • Figure 39. North America Molecular Methods Share (%), by Country
List of companies from research coverage that are profiled in the study
  • QIAGEN (Germany)
  • 3M (United States)
  • Veredus Laboratories (Singapore)
  • Neogen Corporation (United States)
  • Thermo Fisher Scientific (United States)
  • Bio-Rad Laboratories (United States)
  • bioMérieux SA (France)
  • ArcherDX (United States)
  • HiMedia Laboratories (United States)
Additional players considered in the study are as follows:
Eurofins Scientific (Luxembourg) , SGS (Switzerland)
Select User Access Type

Key Highlights of Report


Apr 2024 246 Pages 67 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as QIAGEN (Germany), 3M (United States), Veredus Laboratories (Singapore), Neogen Corporation (United States), Thermo Fisher Scientific (United States), Bio-Rad Laboratories (United States), bioMérieux SA (France), ArcherDX (United States) and HiMedia Laboratories (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"" is seen as one of major influencing trends for Molecular Methods Market during projected period 2023-2030.
The Molecular Methods market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Molecular Methods Market Report?